( 2006 ) Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability . J Natl Cancer Inst 98 : 1521 – 1527 Serum PSA values >4.0 ng/ml are routinely used to select patients for prostate biopsy, although this approach misses some early-...
In the TME, the major protumor function of TAMs is the production of diverse cytokines and growth factors that support the survival and proliferation of cancer cells, suppress their apoptosis, and increase their migratory potential needed for cancer cell invasion and extravasation into the circulation...
Prostate cancer, for example, has a marker known asPSA. Higher levels of PSA in the blood (anything over 4.0 ng/mL) could be a sign of the condition. But you could have high levels of PSA and still not have the disease. For example,prostatitisor benign prostatic hypertrophy could also ...
Can complexed PSA improved the prostate cancer detection rate in men with a “non-suspicious” total PSA ange below 4 NG/ML? — Results of a multicenter trialCan complexed PSA improved the prostate cancer detection rate in men with a “non-suspicious” total PSA ange below 4 NG/ML? — Re...
Even the US Preventative Services Task Force and The National Cancer Institute are opposed to routinePSA testing(the most widely used test for trying to detect cancer). The reason is, they believe the risks of follow-up tests (needle biopsies) may outweigh the possible benefits.(ref: WebMD ...
Moreover, reduction of PSA was observed in five out of eight patients, and no adverse events and side effects were found after treatment. In terms of immunoreaction, seven out of eight patients indicated an increase of CD3-CD56+ NK cells and six patients presented rising proportion of ...
Lilja and colleagues previously reported that serum PSA level in men aged 50 years was a strong predictor of prostate cancer diagnosed up to 25 years afterwards. However, the researchers concede that many prostate cancers do not cause morbidity or mortality and have, therefore, reanalyzed their ...
Objective To evaluate PSA VELOCITY (PSAV) as a surrogate measure of survival time in patients receiving treatment for hormone-refractory, metastatic prostate cancer. Design and intervention Data from men with hormone-refractory, metastatic prostate cancer enrolled in three separate chemotherapeutic ...
D-max the lesion maximum cross-sectional diameter, MR magnetic resonance, MRI-ECE MRI-based extracapsular extension, MRI-LNI MRI-based lymph node involvement, MRI-SVI MRI-based seminal vesicle invasion, PCa prostate cancer, PI-RADS prostate imaging reporting and data system, PSA prostate specific...
Prostate cancer treatment costs increase more rapidly than for any other cancer-how to reverse the trend? EPMA J. 2022, 13, 1–7. [Google Scholar] [CrossRef] Bentley, C.; Cressman, S.; van der Hoek, K.; Arts, K.; Dancey, J.; Peacock, S. Conducting clinical trials-costs, ...